单项选择题

Late-night Drinking

Coffee lovers beware. Having a quick "pick-me-up" cup of coffee1 late in the day will play havoc with your sleep. As well as being a stimulant, caffeine interrupts the flow of melatonin, the brain hormone that sends people into a sleep.
Melatonin levels normally start to rise about two hours before bedtime. Levels then peak between 2 a.m. and 4 a. m. , before falling again. "It’s the neurohormone that controls our sleep and tells our body when to sleep and when to wake," says Maurice Ohayon of the Stanford Sleep Epidemiology Research Center at Stanford University in California. But researchers in Israel have found that caffeinated coffee halves the body’s levels of this sleep hormone.
Lotan Shilo and a team at the Sapir Medical Center in Tel Aviv University found that six volunteers slept less well after a cup of caffeinated coffee than after drinking the same amount of decal. On average, subjects slept 336 minutes per night after drinking caffeinated coffee, compared with 415 minutes after decal. They also took half an hour to drop off-twice as long as usual-and jigged around in bed twice as much.
In the second phase of the experiment, the researchers wolfe the volunteers every three hours and asked them to give a urine sample. Shilo measured concentrations of a breakdown product of melatonin. The results suggest that melatonin concentrations in caffeine drinkers were half those in decal drinkers. In a paper accepted for publication in Sleep Medicinc, the researchers suggest that caffeine blocks production of the enzyme that drives melatonin production.
Because it can take many hours to eliminate caffeine from the body, Ohayon recommends that coffee lovers switch to decal after lunch.
The author mentions "pick-me-up" to indicate that______.

A. melatonin levels need to be raised
B. neurohormone can wake us up
C. coffee is a stimulant
D. decal is a caffeinated coffee
热门 试题

单项选择题
FDA has approved the plan of using HIV to cure cancer in humans. A. Right B. Wrong C. Not mentioned
A team at the California-based Salk Institute, one of the world’s leading research centers on biological sciences, has created a special new breed of HIV and has started negotiations with the US Food and Drug Administration (FDA) to begin clinical gene therapy (治疗) trials this year. The first trials are expected to involve patients suffering from cancers that cannot be cured by surgery although project leader Professor Inder Verma said the HIV technique would have "far wider applications".
The plan remains very likely to cause controversy since it involves making use of a virus which has caused more than 22 million deaths around the world in the past two decades. Verma said that the idea of using HIV for a beneficial purpose was "shocking" but the fierce nature of HIV had disappeared by having all six of the potentially deadly genes removed.
Illnesses such as various cancers are caused when a gene in a patient’s body fails to work properly. In the past two years, breakthroughs in genetics (遗传学) have led gene therapy scientists to try and replace the genes that do not function normally.
Unfortunately, the body’s immune defenses have been known to attack the modified genes and make them lose their effects before they can start their task and progress in the field has been held up by the lack of a suitable carrier.
The HIV virus has the ability to escape from, and then destroy, the immune defense ceils designed to protect our bodies and this makes it attractive to scientists as a way of secretly conveying replacement genes into patients’ bodies.